questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérocycliques avec 4 noyaux ou plus
Ergotamines
Ergotamines : Questions médicales fréquentes
Diagnostic
5
Migraine
Diagnostic médical
Imagerie par résonance magnétique
Migraine
Critères diagnostiques
Migraine
Antécédents familiaux
Migraine
Symptômes
5
Variabilité des symptômes
Migraine
Prévention
5
Prévention des migraines
Déclencheurs de migraine
Régime alimentaire
Migraine
Exercice physique
Migraine
Thérapies alternatives
Migraine
Traitements
5
Ergotamines
Traitement de la migraine
Effets secondaires
Ergotamines
Efficacité du traitement
Ergotamines
Interactions médicamenteuses
Ergotamines
Voie d'administration
Ergotamines
Complications
5
Accident vasculaire cérébral
Migraine
Migraine chronique
Qualité de vie
Fonction cognitive
Migraine
Gestion des complications
Migraine
Facteurs de risque
5
Facteurs de risque
Migraine
Fluctuations hormonales
Migraine
Habitudes alimentaires
Migraine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ergotamines : Questions médicales les plus fréquentes",
"headline": "Ergotamines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ergotamines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ergotamines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"url": "https://questionsmedicales.fr/mesh/D006576",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"code": {
"@type": "MedicalCode",
"code": "D006576",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromocriptine",
"alternateName": "Bromocriptine",
"url": "https://questionsmedicales.fr/mesh/D001971",
"about": {
"@type": "MedicalCondition",
"name": "Bromocriptine",
"code": {
"@type": "MedicalCode",
"code": "D001971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocornine",
"alternateName": "Dihydroergocornine",
"url": "https://questionsmedicales.fr/mesh/D025441",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocornine",
"code": {
"@type": "MedicalCode",
"code": "D025441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocristine",
"alternateName": "Dihydroergocristine",
"url": "https://questionsmedicales.fr/mesh/D025442",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocristine",
"code": {
"@type": "MedicalCode",
"code": "D025442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "alpha-Dihydroergocryptine",
"alternateName": "Dihydroergocryptine",
"url": "https://questionsmedicales.fr/mesh/D025443",
"about": {
"@type": "MedicalCondition",
"name": "alpha-Dihydroergocryptine",
"code": {
"@type": "MedicalCode",
"code": "D025443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotamine",
"alternateName": "Dihydroergotamine",
"url": "https://questionsmedicales.fr/mesh/D004087",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotoxine",
"alternateName": "Dihydroergotoxine",
"url": "https://questionsmedicales.fr/mesh/D004088",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotoxine",
"code": {
"@type": "MedicalCode",
"code": "D004088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"alternateName": "Ergoloid Mesylates",
"url": "https://questionsmedicales.fr/mesh/D004877",
"about": {
"@type": "MedicalCondition",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"code": {
"@type": "MedicalCode",
"code": "D004877",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ergotamine",
"alternateName": "Ergotamine",
"url": "https://questionsmedicales.fr/mesh/D004878",
"about": {
"@type": "MedicalCondition",
"name": "Ergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004878",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ergotamines",
"alternateName": "Ergotamines",
"code": {
"@type": "MedicalCode",
"code": "D004879",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Manoj B Kudupoje",
"url": "https://questionsmedicales.fr/author/Manoj%20B%20Kudupoje",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Eric S Vanzant",
"url": "https://questionsmedicales.fr/author/Eric%20S%20Vanzant",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Kyle R McLeod",
"url": "https://questionsmedicales.fr/author/Kyle%20R%20McLeod",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Alexandros Yiannikouris",
"url": "https://questionsmedicales.fr/author/Alexandros%20Yiannikouris",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Wiebke Rudolph",
"url": "https://questionsmedicales.fr/author/Wiebke%20Rudolph",
"affiliation": {
"@type": "Organization",
"name": "a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Rapid and Sensitive Stability-Indicating Eco-Friendly HPTLC Assay for Fluorescence Detection of Ergotamine.",
"datePublished": "2023-06-29",
"url": "https://questionsmedicales.fr/article/37446763",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28135101"
}
},
{
"@type": "ScholarlyArticle",
"name": "First Synthesis of Ergotamine-",
"datePublished": "2024-04-20",
"url": "https://questionsmedicales.fr/article/38668624",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/toxins16040199"
}
},
{
"@type": "ScholarlyArticle",
"name": "Use of 3D applicator for intranasal microneedle arrays for combinational therapy in migraine.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36773727",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2023.122714"
}
},
{
"@type": "ScholarlyArticle",
"name": "In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/35807455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules27134210"
}
},
{
"@type": "ScholarlyArticle",
"name": "Finding alternatives to 5-fluorouracil: application of ensemble-based virtual screening for drug repositioning against human thymidylate synthase.",
"datePublished": "2022-05-10",
"url": "https://questionsmedicales.fr/article/35538714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07391102.2022.2074140"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"item": "https://questionsmedicales.fr/mesh/D006576"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ergotamines",
"item": "https://questionsmedicales.fr/mesh/D004879"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ergotamines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ergotamines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ergotamines",
"description": "Comment diagnostiquer une migraine ?\nQuels tests sont utilisés pour les migraines ?\nLes ergots sont-ils prescrits pour d'autres maux de tête ?\nQuels critères sont utilisés pour le diagnostic ?\nLes antécédents familiaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004879#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ergotamines",
"description": "Quels sont les symptômes d'une migraine ?\nLes migraines provoquent-elles des vomissements ?\nY a-t-il des signes avant-coureurs de migraine ?\nLes migraines peuvent-elles causer des vertiges ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D004879#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ergotamines",
"description": "Comment prévenir les migraines ?\nLes changements alimentaires aident-ils à prévenir les migraines ?\nLe stress influence-t-il la fréquence des migraines ?\nLes exercices physiques aident-ils à prévenir les migraines ?\nLes thérapies alternatives sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D004879#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ergotamines",
"description": "Comment les ergots soulagent-ils les migraines ?\nQuels sont les effets secondaires des ergots ?\nLes ergots sont-ils efficaces pour tous les patients ?\nPeut-on combiner les ergots avec d'autres médicaments ?\nQuelle est la voie d'administration des ergots ?",
"url": "https://questionsmedicales.fr/mesh/D004879#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ergotamines",
"description": "Quelles sont les complications possibles des migraines ?\nLes migraines peuvent-elles entraîner des AVC ?\nLes migraines chroniques ont-elles des conséquences ?\nLes migraines peuvent-elles causer des problèmes cognitifs ?\nComment gérer les complications des migraines ?",
"url": "https://questionsmedicales.fr/mesh/D004879#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ergotamines",
"description": "Quels sont les facteurs de risque des migraines ?\nL'âge influence-t-il le risque de migraines ?\nLes changements hormonaux affectent-ils les migraines ?\nLe manque de sommeil est-il un facteur de risque ?\nLes habitudes alimentaires influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D004879#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une migraine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique des symptômes et des examens neurologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les migraines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM peuvent être utilisés pour exclure d'autres causes."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils prescrits pour d'autres maux de tête ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont principalement prescrits pour les migraines, pas pour d'autres types de céphalées."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, la durée et l'intensité des crises de migraine."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de migraines peuvent augmenter la probabilité de diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une migraine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs pulsatiles, des nausées et une sensibilité à la lumière."
}
},
{
"@type": "Question",
"name": "Les migraines provoquent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements peuvent accompagner les migraines chez certains patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes avant-coureurs de migraine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles visuels ou des picotements peuvent précéder une migraine."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des vertiges ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent des vertiges ou des étourdissements pendant une crise."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les migraines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs connus, maintenir un mode de vie sain et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils à prévenir les migraines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments peuvent déclencher des migraines, leur évitement peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la fréquence des migraines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress est un déclencheur courant des migraines et sa gestion est cruciale."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils à prévenir les migraines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité physique régulière peut réduire la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les thérapies alternatives sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies comme l'acupuncture peuvent aider à réduire la fréquence des migraines."
}
},
{
"@type": "Question",
"name": "Comment les ergots soulagent-ils les migraines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots agissent en constrictant les vaisseaux sanguins et en réduisant l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des ergots ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils efficaces pour tous les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité peut varier et certains patients peuvent ne pas y répondre."
}
},
{
"@type": "Question",
"name": "Peut-on combiner les ergots avec d'autres médicaments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quelle est la voie d'administration des ergots ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots peuvent être administrés par voie orale, nasale ou injectable selon le cas."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des migraines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de l'humeur, des problèmes de sommeil et des AVC."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines avec aura peuvent augmenter le risque d'accident vasculaire cérébral."
}
},
{
"@type": "Question",
"name": "Les migraines chroniques ont-elles des conséquences ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affecter la qualité de vie et entraîner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des problèmes cognitifs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les migraines fréquentes peuvent affecter la cognition."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des migraines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins et psychologues est souvent nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des migraines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le sexe féminin, et le stress."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de migraines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines sont plus fréquentes chez les jeunes adultes et les femmes d'âge moyen."
}
},
{
"@type": "Question",
"name": "Les changements hormonaux affectent-ils les migraines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les fluctuations hormonales, notamment pendant le cycle menstruel, peuvent déclencher des migraines."
}
},
{
"@type": "Question",
"name": "Le manque de sommeil est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le manque de sommeil peut augmenter la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments et boissons peuvent déclencher des migraines chez certaines personnes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States.
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
1 publication dans cette catégorie
Affiliations :
Division 1.7, Organic Trace and Food Analysis, Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. 11, 12489 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Toxicology, Technische Universität Berlin, Gustav-Meyer-Allee 25, 13355 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Division 1.7, Organic Trace and Food Analysis, Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. 11, 12489 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneshwar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Urology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
Eco-friendly liquid chromatographic methods for measuring ergotamine (EGT) are scant in the published database. Accordingly, the goal of the current study was to develop a high-performance thin-layer ...
Ergot alkaloids (EAs) formed by...
The objective of current research work was to fabricate dissolving microneedles combining ergotamine and caffeine for synergistic action using controlled release kinetics with better permeability. The...
COVID-19, a pandemic caused by the virus SARS-CoV-2, has spread globally, necessitating the search for antiviral compounds. Transmembrane protease serine 2 (TMPRSS2) is a cell surface protease that pl...
5-fluorouracil and analogs are used in the treatment of many solid tumours. However, there are many cases of resistance and high toxicity associated with 5-fluorouracil chemotherapy. Repurposing FDA d...
This work evaluates the potential of ion mobility spectrometry (IMS) to improve the analytical performance of current liquid chromatography-mass spectrometry (LC-MS) workflows applied to the determina...
Alzheimer's disease (AD) is a neurodegenerative disorder that is the most common form of dementia in the elderly. The drugs currently used to treat AD only have limited effects and are not able to cur...
To screen potential drug candidates for AD based on the relationship between risk genes of AD and drugs....
We collected the risk genes of AD and retrieved the information of known drugs from DrugBank. Then, the AD-related genes and the targets of each drug were mapped to the human protein-protein interacti...
We compiled a list of 714 genes associated with AD. From 5,833 drugs used for human diseases, we identified 1,044 drugs that could be potentially used to treat AD. Then, amyloid-β (Aβ) protein, the ke...
Our work indicated that ergotamine and RAF-265 may be potential candidates for treating AD....
This research work aimed to form vesosomes using combination of two drugs ergotamine (ERG) and caffeine for synergistic activity when given intranasally resulting in faster absorption, steric stabilit...
The multicompartment vesicles viz., vesosomes of ERG tartrate proved to increase absorption of drugs post-intranasal administration, bypassing the blood-brain barrier...
The phospholipids like soya lecithin, cholesterol, and dipalmitoyl phosphatidylcholine (DPPC) were used to form a multicompartment structure called vesosomes using ethanol-induced interdigitation of l...
The formulation showed low particle size (PS) of 315.48 ± 14.27 nm with zeta potential (ZP) of -21.78 ± 4.72 mV, higher % EE of 91.13 ± 1.29%, and controlled release kinetics, when assessed for...
The stable vesosomes prepared using interdigitation of saturated phospholipids proved to be a viable option for ERG when administered intranasally for better absorption and bioavailability coupled wit...
(1) Background: The N-methyl-D-aspartate receptors (NMDARs) mediate fast excitatory currents leading to depolarization. Postsynaptic NMDARs are ionotropic glutamate receptors that mediate excitatory g...
Triptans and ergotamine are commonly used to treat migraine, a risk factor for ischemic stroke. This study aimed to investigate the association between migraine and ischemic cardio-cerebrovascular dis...
Participants from the Korean NHIS-HEALS cohort database were divided into patients reporting headache without migraine (HA), migraineurs who received at least one prescription for triptans or ergotami...
Among 62,272 patients diagnosed with migraine or HA, men with migraine or HA numbered 14,747 and 8935, respectively, while the numbers of women were 27,836 and 10,754, respectively. The median follow-...
Migraine increased the risk of ischemic CCVDs in both sexes, and migraineurs treated with triptans and ergotamine were at lower risk of ischemic CCVDs than migraineurs who did not take those medicatio...